Aclarion Inc. announced the launch of a program aimed at developing a statewide network of providers in New Jersey to utilize its AI technology, Nociscan, for the personal injury and workers compensation sectors. Dr. Justin Kubeck, an orthopedic surgeon and founder of Ocean Pain and Spine in Toms River, N.J., will lead this initiative to enhance the evaluation of chronic low back pain patients in these systems.
Kubeck said, “The personal injury and workers compensation ecosystem involves a discrete number of judges and lawyers who work to adjudicate claims leveraging the expertise of physicians dedicated to understanding this unique segment of the healthcare system. The nature of these claims mandates an objective and definitive diagnosis, knowing that the diagnosis may well be challenged in a legal setting. The use of Nociscan can be a powerful objective measurement tool to provide a strong case for supporting an appropriate treatment pathway.”
He added, “Over the next several months, I will be working to educate the network of judges and lawyers who determine the appropriateness of recommended treatments on the value Nociscan brings to my patients and the value I think it can bring to improving the workers compensation and personal injury evaluation process.”
Claims involving neck and back injuries have considerable financial implications, with the average settlement for personal injury claims in New Jersey reaching $918,967, while work-related accidents that cause similar injuries average $148,750 nationally. Nociscan aims to provide crucial objective data to aid healthcare providers in determining appropriate treatment plans.
Ryan Bond, chief strategy officer of Aclarion, stated, “Once established in New Jersey, we will target other markets throughout the United States to replicate the success of the NJ market. We believe this population is the perfect fit for the use of advanced biomarker identifications correlated to pain and available exclusively through the Nociscan platform.”
Aclarion develops healthcare technology utilizing Magnetic Resonance Spectroscopy and other proprietary methods to optimize clinical treatments, particularly for chronic low back pain.